DexCom, Inc. (DXCM) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 San Diego, CA, 미국. 현재 CEO는 Jacob Steven Leach.
DXCM 을(를) 보유 IPO 날짜 2005-04-14, 10,200 명의 정규직 직원, 에 상장 NASDAQ Global Select, 시가총액 $24.55B.
DexCom, Inc. is a medical device company headquartered in San Diego, California, specializing in the design, development, and commercialization of continuous glucose monitoring (CGM) systems for diabetes management. The company's product portfolio includes the DexCom G6 integrated CGM system, DexCom ONE for replacing traditional finger-stick blood glucose testing, DexCom Share for remote monitoring, and the Dexcom Real-Time API that enables third-party developers to integrate CGM data into digital health applications. DexCom markets its solutions directly to endocrinologists, physicians, diabetes educators, and healthcare providers across the United States and internationally, with the next-generation G7 system under development. The company also partners with Verily Life Sciences to develop advanced blood-based and interstitial glucose monitoring products.
